Evidence map›Paper›PMID 29324806›Full record

ArticlePloS one2018

Immunocompetent host develops mild intestinal inflammation in acute infection with Toxoplasma gondii.

Paulo da Silva Watanabe, Aline Rosa Trevizan, Saulo Euclides Silva-Filho, Marcelo Biondaro Góis, João Luiz Garcia, Roberto Kenji Nakamura Cuman, Ana Cristina Breithaupt-Faloppa, Débora de Mello Gonçales Sant Ana, Gessilda de Alcantara Nogueira de Melo

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Mechanism of allergic rhinitis treated byPharmaceutical biology · 2021
    Article
  5. Review
  6. Presence of Toxoplasma gondii infection in brain as a potential cause of risky behavior: a report of 102 autopsy cases.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Paulo da Silva WatanabeBiosciences and Physiopathology Program, Universidade Estadual de Maringá, Maringá, Paraná, Brazil.ORCID 0000-0002-5134-233X
Aline Rosa TrevizanBiosciences and Physiopathology Program, Universidade Estadual de Maringá, Maringá, Paraná, Brazil.
Saulo Euclides Silva-FilhoPharmaceutical Sciences Graduate Program, Universidade Estadual de Maringá, Maringá, Paraná, Brazil.
Marcelo Biondaro GóisBiosciences and Physiopathology Program, Universidade Estadual de Maringá, Maringá, Paraná, Brazil.
João Luiz GarciaUniversidade Estadual de Londrina, Londrina, Paraná, Brazil.
Roberto Kenji Nakamura CumanPharmaceutical Sciences Graduate Program, Universidade Estadual de Maringá, Maringá, Paraná, Brazil.
Ana Cristina Breithaupt-FaloppaHeart Institute (InCor), LIM 11, Universidade de São Paulo-Medical School, São Paulo, São Paulo, Brazil.
Débora de Mello Gonçales Sant AnaBiosciences and Physiopathology Program, Universidade Estadual de Maringá, Maringá, Paraná, Brazil.
Gessilda de Alcantara Nogueira de MeloBiosciences and Physiopathology Program, Universidade Estadual de Maringá, Maringá, Paraná, Brazil.
Universidade Estadual de Maringá · BRUniversidade de São Paulo · BRUniversidade Estadual de Londrina · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Toxoplasma gondii (T. gondii) is the causative agent of toxoplasmosis, common zoonosis among vertebrates and high incidence worldwide. During the infection, the parasite needs to transpose the intestinal barrier to spread throughout the body, which may be a trigger for an inflammatory reaction. This work evaluated the inflammatory alterations of early T. gondii infection in peripheral blood cells, in the mesenteric microcirculation, and small intestinal tissue by measurement of MPO (myeloperoxidase) activity and NO (nitric oxide) level in rats. Animals were randomly assigned into control group (CG) that received saline orally and groups infected with 5,000 oocysts for 6 (G6), 12 (G12), 24 (G24), 48 (G48) and 72 hours (G72). Blood samples were collected for total and differential leukocyte count. Intravital microscopy was performed in the mesentery to evaluate rolling and adhesion of leukocytes. After euthanasia, 0.5cm of the duodenum, jejunum and ileum were collected for the determination of MPO activity, NO level and PCR to identify the parasite DNA and also the mesentery were collected to perform immunohistochemistry on frozen sections to quantify adhesion molecules ICAM-1, PECAM-1 and P-Selectin. The parasite DNA was identified in all infected groups and there was an increase in leukocytes in the peripheral blood and in expression of ICAM-1 and PECAM-1 in G6 and G12, however, the expression of P-selectin was reduced in G12. Leukocytes are in rolling process during the first 12 hours and they are adhered at 24 hours post-infection. The activity of MPO increased in the duodenum at 12 hours, and NO increased in the jejunum in G72 and ileum in G24, G48 and G72. Our study demonstrated that T. gondii initiates the infection precociously (at 6 hours) leading to a systemic activation of innate immune response resulting in mild inflammation in a less susceptible experimental model.

Indexed as

ImmunocompetenceAcute DiseaseAnimalsInflammationIntercellular Adhesion Molecule-1IntestinesNitric OxidePeroxidaseRatsReal-Time Polymerase Chain ReactionToxoplasmaToxoplasmosis, AnimalIntercellular Adhesion Molecule-1Nitric OxidePeroxidase

Identifiers

PMID29324806
PMCPMC5764246
OpenAlexW2782717555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.